<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Bioinformatic Brothers: Projects</title>

    <!-- Bootstrap -->
    <link href="articles/css/bootstrap.min.css" rel="stylesheet">
    <link rel="articles/stylesheet" href="css/font-awesome.min.css">
    <link rel="articles/stylesheet" href="css/font-awesome.css">
    <link rel="articles/stylesheet" href="css/animate.css">
    <link href="articles/css/style.css" rel="stylesheet"/>
    <!-- =======================================================
      Theme Name: Anyar
      Theme URL: https://bootstrapmade.com/anyar-free-multipurpose-one-page-bootstrap-theme/
      Author: BootstrapMade
      Author URL: https://bootstrapmade.com
    ======================================================= -->
</head>

<body>
<header>
    <nav class="navbar navbar-default navbar-fixed-top" role="navigation">
        <div class="navigation">
            <div class="container">
                <div class="navbar-header">
                    <button type="button" class="navbar-toggle collapsed" data-toggle="collapse"
                            data-target=".navbar-collapse.collapse">
                        <span class="sr-only">Toggle navigation</span>
                        <span class="icon-bar"></span>
                        <span class="icon-bar"></span>
                        <span class="icon-bar"></span>
                    </button>
                    <div class="navbar-brand">
                        <a href="index.html"><h1>BIOINFORMATIC BROTHERS</h1></a>
                    </div>
                </div>

                <div class="navbar-collapse collapse">
                    <div class="menu">
                        <ul class="nav nav-tabs" role="tablist">
                            <li role="presentation"><a href="index.html">Home</a></li>
                            <li role="presentation"><a href="#home" class="active">Top</a></li>
                            <li role="presentation"><a href="#about">Articles</a></li>
                            <li role="presentation"><a href="#01">Comments</a></li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </nav>
</header>

<div id="home">
    <div class="slider">
        <div class="">
            <div id="about-slider">
                <div id="carousel-slider" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators visible-xs">
                        <li data-target="#carousel-slider" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-slider" data-slide-to="1"></li>
                        <li data-target="#carousel-slider" data-slide-to="2"></li>
                    </ol>

                    <div class="carousel-inner">
                        <div class="item active">
                            <img src="articles/img/3.jpg" class="img-responsive" alt="">
                        </div>
                        <div class="item">
                            <img src="articles/img/3.jpg" class="img-responsive" alt="">
                        </div>
                        <div class="item">
                            <img src="articles/img/3.jpg" class="img-responsive" alt="">
                        </div>
                    </div>

                    <a class="left carousel-control hidden-xs" href="#carousel-slider" data-slide="prev">
                        <i class="fa fa-angle-left"></i>
                    </a>

                    <a class=" right carousel-control hidden-xs" href="#carousel-slider" data-slide="next">
                        <i class="fa fa-angle-right"></i>
                    </a>
                </div>
                <!--/#carousel-slider-->
            </div>
            <!--/#about-slider-->
        </div>
    </div>
</div>

<section id="about">
    <div class="container">
        <div class="center">
            <div class="col-md-6 col-md-offset-3">
                <h2>ARTICLES</h2>
                <!--          <hr>-->
                <p class="lead">Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
                    incididunt ut</p>
            </div>
        </div>
        <!-- articles zone begin -->
        <div class="row">
            <div id="integration-list">
                <ul>
                    <!-- To add any new article, duplicate <li> tag | Always add here the most recent article-->
                    <!-- Begin of article -->
                    <li>
                        <a class="expand">
                            <div style="line-height: 22px">
                                <div class="text-center journal">
                                    <img src="articles/img/acschemneuro-logo.gif" width="100%" height="auto"/>
                                </div>
                                <div class="article">
                                    <h2>Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for
                                        Alzheimer’s Disease</h2>
                                    <span>Doens, Deborah; <b>Valdés-Tresanco, Mario E. </b> ; Vasquez, Velmarini;
                                      Carreira, Maria Beatriz; De La Guardia, Yila; Stephens, David E.; Nguyen, Viet D.;
                                      Nguyen, Vu T.; Gu, Jianhua; Hegde, Muralidhar L.; Larionov, Oleg V.; Valiente,
                                      Pedro A.; Lleonart, Ricardo; Fernández, Patricia L.</span>
                                </div>
                            </div>

                        </a>
                        <div class="detail">
                            <div class="cover">
                                <div class="sup">
                                    <div style="height: 80%">
                                        <img src="articles/img/acschemneuro-cover.jpg" width="100%"/>
                                    </div>
                                </div>
                            </div>
                            <div class="abstract">
                                <div class="sup">
                                    <h4>Abstract</h4>
                                    Alzheimer’s disease (AD) is the most common form of dementia among the elderly and
                                    has become a leading public health concern worldwide. It represents a huge economic
                                    and psychological burden to caregivers and families. The presence of extracellular
                                    amyloid beta (Aβ) plaques is one of the hallmarks of this neurodegenerative
                                    disorder. Amyloid plaques are comprised of aggregates of Aβ peptides, mainly Aβ42,
                                    originated by the cleavage of the amyloid precursor protein (APP). Aβ is a crucial
                                    target for the treatment of AD, but to date, no effective treatment for the
                                    clearance of Aβ has been found. We have identified four new hexahydropyrroloindoles
                                    (HPI) synthetic compounds that are able to inhibit the aggregation of Aβ42 and/or
                                    disaggregate the fibril. Docking experiments suggest that the nonpolar component of
                                    the interaction of compounds with Aβ42 contributes favorably to the binding free
                                    energy of each complex. Molecular dynamics simulations suggested fibril
                                    disaggregating activity of compounds 1 via interaction with hydrophobic moieties of
                                    the fibril. Consistently, compounds 1 and 2 were able to mitigate Aβ42 fibrils
                                    induced death in rat pheochromocytoma cells (PC 12). One of the compounds reduces
                                    the formation of Aβ aggregates in vivo and the paralysis associated with Aβ toxicity
                                    in Caenorhabditis elegans. Our study thus augments efforts for the identification
                                    and characterization of new agents that may help stop or delay the progression of
                                    AD.</span>
                                    <br>
                                    <br>
                                    <a class="link" href="https://pubs.acs.org/doi/10.1021/acschemneuro.9b00297">Go to
                                        Journal</a>
                                </div>
                            </div>
                        </div>
                    </li>
                    <!-- ENd of article-->
                    <li>
                        <a class="expand">
                            <div style="line-height: 22px">
                                <div class="text-center journal">
                                    <img src="articles/img/bj-logo.jpg" width="100%" height="auto"/>
                                </div>
                                <div class="article">
                                    <h2>Membrane Remodeling by the Lytic Fragment of SticholysinII: Implications for the
                                        Toroidal
                                        Pore Model</h2>
                                    <span>Mesa-Galloso, Haydee; Valiente, Pedro A.; <b>Valdés-Tresanco, Mario E.</b>; Epand, Raquel
                        F.; Lanio, Maria E.; Epand, Richard M.; Alvarez, Carlos; Tieleman, D. Peter; Ros, Uris</span>
                                </div>
                            </div>
                        </a>
                        <div class="detail">
                            <div class="cover">
                                <div class="sup">
                                    <div style="height: 80%">
                                        <img src="articles/img/acschemneuro-cover.jpg" width="100%"/>
                                    </div>
                                </div>
                            </div>
                            <div class="abstract">
                                <div class="sup">
                                    <h4>Abstract</h4>
                                    Sticholysins are pore-forming toxins of biomedical interest and represent a
                                    prototype of proteins acting through the formation of protein-lipid or toroidal
                                    pores. Peptides spanning the N-terminus of sticholysins can mimic their
                                    permeabilizing activity and, together with the full-length toxins, have been used as
                                    a tool to understand the mechanism of pore formation in membranes. However, the
                                    lytic mechanism of these peptides and the lipid shape modulating their activity are
                                    not completely clear. In this article, we combine molecular dynamics simulations and
                                    experimental biophysical tools to dissect different aspects of the pore-forming
                                    mechanism of StII1?30, a peptide derived from the N-terminus of sticholysin II
                                    (StII). With this combined approach, membrane curvature induction and flip-flop
                                    movement of the lipids were identified as two important membrane remodeling steps
                                    mediated by StII1?30. Pore formation by this peptide was enhanced by the presence of
                                    the negatively curved lipid phosphatidylethanolamine in membranes. This lipid
                                    emerged not only as a facilitator of membrane interactions but also as a structural
                                    element of the StII1?30 pore that is recruited to the ring upon its assembly.
                                    Collectively, these, to our knowledge, new findings support a toroidal model for the
                                    architecture of the pore formed by StII1?30 and provide new molecular insight into
                                    the role of phosphatidylethanolamine as a membrane component that can easily
                                    integrate into the ring of toroidal pores, thus probably aiding in their
                                    stabilization. This study contributes to a better understanding of the molecular
                                    mechanism underlying the permeabilizing activity of StII1?30 and peptides or
                                    proteins acting via a toroidal pore mechanism and offers an informative framework
                                    for the optimization of the biomedical application of this and similar
                                    molecules.</span>
                                    <br>
                                    <br>
                                    <a class="link" href="https://www.cell.com/biophysj/fulltext/S0006-3495(19)30793-3">Go
                                        to Journal</a>
                                </div>
                            </div>
                        </div>

                    </li>
                    <li>
                        <a class="expand">
                            <div style="line-height: 22px">
                                <div class="text-center journal">
                                    <img src="articles/img/ejmc-logo.jpg" width="100%" height="auto"/>
                                </div>
                                <div class="article">
                                    <h2>Discovery of potent and selective inhibitors of the Escherichia coli
                                        M1-aminopeptidase via
                                        multicomponent solid-phase synthesis of tetrazole-peptidomimetics.</h2>
                                    <span>Méndez, Yanira; De Armas, German; Pérez, Idalia; Rojas, Tamara; <b>Valdés-Tresanco, Mario
                        E. </b> ; Izquierdo, Maikel; Alonso del Rivero, Maday; Álvarez-Ginarte, Yoanna María;
                        Valiente, Pedro A.; Soto, Carmen; de León, Lena; Vasco, Aldrin V.; Scott, William L.;
                        Westermann, Bernhard; González-Bacerio, Jorge; Rivera, Daniel G.</span>
                                </div>
                            </div>
                        </a>
                        <div class="detail">
                            <div class="cover">
                                <div class="sup">
                                    <div style="height: 80%">
                                        <img src="articles/img/ejmc-cover.jpg" width="100%"/>
                                    </div>
                                </div>
                            </div>
                            <div class="abstract">
                                <div class="sup">
                                    <h4>Abstract</h4>
                                    The Escherichia coli neutral M1-aminopeptidase (ePepN) is a novel target identified
                                    for the development of antimicrobials. Here we describe a solid-phase multicomponent
                                    approach which enabled the discovery of potent ePepN inhibitors. The on-resin
                                    protocol, developed in the frame of the Distributed Drug Discovery (D3) program,
                                    comprises the implementation of parallel Ugi-azide four-component reactions with
                                    resin-bound amino acids, thus leading to the rapid preparation of a focused library
                                    of tetrazole-peptidomimetics (TPMs) suitable for biological screening. By
                                    dose-response studies, three compounds were identified as potent and selective ePepN
                                    inhibitors, as little inhibitory effect was exhibited for the porcine ortholog
                                    aminopeptidase. The study allowed for the identification of the key structural
                                    features required for a high ePepN inhibitory activity. The most potent and
                                    selective inhibitor (TPM 11) showed a non-competitive inhibition profile of ePepN.
                                    We predicted that both diastereomers of compound TPM 11 bind to a site distinct from
                                    that occupied by the substrate. Theoretical models suggested that TPM 11 has an
                                    alternative inhibition mechanism that doesn't involve Zn coordination. On the other
                                    hand, the activity landscape analysis provided a rationale for our findings. Of
                                    note, compound TMP 2 showed in vitro antibacterial activity against Escherichia
                                    coli. Furthermore, none of the three identified inhibitors is a potent haemolytic
                                    agent, and only two compounds showed moderate cytotoxic activity toward the murine
                                    myeloma P3X63Ag cells. These results point to promising compounds for the future
                                    development of rationally designed TPMs as antibacterial agents.</span>
                                    <br>
                                    <br>
                                    <a class="link"
                                       href="https://www.sciencedirect.com/science/article/pii/S0223523418310365?via%3Dihub">Go
                                        to Journal</a>
                                </div>
                            </div>
                        </div>

                    </li>
                    <li>
                        <a class="expand">
                            <div style="line-height: 22px">
                                <div class="text-center journal">
                                    <img src="articles/img/biochimie-logo.jpg" width="100%" height="auto"/>
                                </div>
                                <div class="article">
                                    <h2>Discovery of novel non-competitive inhibitors of mammalian neutral M1
                                        aminopeptidase
                                        (APN)</h2>
                                    <span>Pascual, Isel; Valiente, Pedro A.; García, Gabriela; <b>Valdés-Tresanco, Mario E.</b>;
                        Arrebola, Yarini; Díaz, Lisset; Bounaadja, Lotfi; Uribe, Rosa María; Pacheco, Mae Chappé;
                        Florent, Isabelle; Charli, Jean-Louis</span>
                                </div>
                            </div>
                        </a>
                        <div class="detail">
                            <div class="cover">
                                <div class="sup">
                                    <div style="height: 80%">
                                        <img src="articles/img/biochimie-cover.jpg" width="100%"/>
                                    </div>
                                </div>
                            </div>
                            <div class="abstract">
                                <div class="sup">
                                    <h4>Abstract</h4>
                                    Neutral metallo-aminopeptidase (APN) catalyzes the cleavage of neutral and basic
                                    amino acids from the N-terminus of protein or peptide substrates. APN expression is
                                    dysregulated in inflammatory diseases as well as in several types of cancer.
                                    Therefore, inhibitors of APN may be effective against cancer and inflammation. By
                                    virtual screening and enzymatic assays, we identified three non-competitive
                                    inhibitors (α > 1) of the porcine and human APN with Ki values in the μM range.
                                    These non-peptidic compounds lack the classical zinc-binding groups (ZBG) present in
                                    most of the APN inhibitors. Molecular docking simulations suggested the novel
                                    inhibitors suppress APN activity by an alternative mechanism to Zn coordination:
                                    they interacted with residues comprising the S1 and S5′ subsites of APN. Of note,
                                    these compounds also inhibited the porcine aminopeptidase A (pAPA) using a
                                    competitive inhibition mode. This indicated differences in the binding mode of these
                                    compounds with APN and APA. Based on sequence and structural analyses, we predicted
                                    the significance of targeting human APN residues: Ala-351, Arg-442, Ala-474, Phe-896
                                    and Asn-900 for improving the selectivity of the identified compounds. Remarkably,
                                    the intraperitoneal injection of compounds BTB07018 and JFD00064 inhibited APN
                                    activity in rat brain, liver and kidney indicating good bio-distribution of these
                                    inhibitors in vivo. These data reinforce the idea of designing novel APN inhibitors
                                    based on lead compounds without ZBG.</span>
                                    <br>
                                    <br>
                                    <a class="link"
                                       href="https://www.sciencedirect.com/science/article/abs/pii/S0300908417302390?via%3Dihub">Go
                                        to Journal</a>
                                </div>
                            </div>
                        </div>

                    </li>
                    <li>
                        <a class="expand">
                            <div style="line-height: 22px">
                                <div class="text-center journal">
                                    <img src="articles/img/jmr-logo.jpg" width="100%" height="auto"/>
                                </div>
                                <div class="article">
                                    <h2>Protein surface roughness accounts for binding free energy of Plasmepsin
                                        II-ligand complexes</h2>
                                    <span><b>Valdés-Tresanco, Mario E.</b>; <b>Valdés-Tresanco, Mario S.</b>; Valiente,
                                      Pedro A.; Cocho, Germinal; Mansilla, Ricardo; Nieto-Villar, J. M.</span>
                                </div>
                            </div>
                        </a>
                        <div class="detail">
                            <div class="cover">
                                <div class="sup">
                                    <div style="height: 80%">
                                        <img src="articles/img/jmr-cover.gif" width="100%"/>
                                    </div>
                                </div>
                            </div>
                            <div class="abstract">
                                <div class="sup">
                                    <h4>Abstract</h4>
                                    The calculation of absolute binding affinities for protein-inhibitor complexes
                                    remains as one of the main challenges in computational structure-based ligand
                                    design. The present work explored the calculations of surface fractal dimension (as
                                    a measure of surface roughness) and the relationship with experimental binding free
                                    energies of Plasmepsin II complexes. Plasmepsin II is an attractive target for novel
                                    therapeutic compounds to treat malaria. However, the structural flexibility of this
                                    enzyme is a drawback when searching for specific inhibitors. Concerning that, we
                                    performed separate explicitly solvated molecular dynamics simulations using the
                                    available high-resolution crystal structures of different Plasmepsin II complexes.
                                    Molecular dynamics simulations allowed a better approximation to systems dynamics
                                    and, therefore, a more reliable estimation of surface roughness. This constitutes a
                                    novel approximation in order to obtain more realistic values of fractal dimension,
                                    because previous works considered only x-ray structures. Binding site fractal
                                    dimension was calculated considering the ensemble of structures generated at
                                    different simulation times. A linear relationship between binding site fractal
                                    dimension and experimental binding free energies of the complexes was observed
                                    within 20 ns. Previous studies of the subject did not uncover this relationship.
                                    Regression model, coined FD model, was built to estimate binding free energies from
                                    binding site fractal dimension values. Leave-one-out cross-validation showed that
                                    our model reproduced accurately the absolute binding free energies for our training
                                    set (R2 = 0.76; |error| =0.55 kcal/mol; SDerror = 0.19 kcal/mol). The fact that such
                                    a simple model may be applied raises some questions that are addressed in the
                                    article.</span>
                                    <br>
                                    <br>
                                    <a class="link" href="https://onlinelibrary.wiley.com/doi/abs/10.1002/jmr.2661">Go
                                        to Journal</a>
                                </div>
                            </div>
                        </div>

                    </li>
                </ul>
            </div>
        </div>
        <!-- articles zone end -->
    </div>
</section>

<section id="comments">
    <div class="container">
        <div id="disqus_thread"></div>
        <script>
            /**
             *  RECOMMENDED CONFIGURATION VARIABLES: EDIT AND UNCOMMENT THE SECTION BELOW TO INSERT DYNAMIC VALUES FROM YOUR PLATFORM OR CMS.
             *  LEARN WHY DEFINING THESE VARIABLES IS IMPORTANT: https://disqus.com/admin/universalcode/#configuration-variables*/
                // /*
            var disqus_config = function () {
                    this.page.url = 'https://bioinformaticbrothers.github.io/web/articles.html';
                    // Replace PAGE_URL with your page's canonical URL variable
                    this.page.identifier = articles; // Replace PAGE_IDENTIFIER with your page's unique identifier variable
                };
            // */
            (function () { // DON'T EDIT BELOW THIS LINE
                var d = document, s = d.createElement('script');
                s.src = 'https://bioinformaticbrothers.disqus.com/embed.js';
                s.setAttribute('data-timestamp', +new Date());
                (d.head || d.body).appendChild(s);
            })();
        </script>
        <noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by
            Disqus.</a></noscript>
    </div>
</section>
<footer>
    <div class="container">
        <div class="col-md-6 wow fadeInDown" data-wow-duration="1000ms" data-wow-delay="300ms">
            <h4>About Us</h4>
            <p>Anyar is tellus ac cursus commodo, mauesris condime ntum nibh, ut fermentum mas justo sitters.</p>
            <div class="contact-info">
                <ul>
                    <li><i class="fa fa-envelope fa"></i> info@domain.net</li>
                </ul>
            </div>
        </div>

        <div class="col-md-6 wow fadeInDown" data-wow-duration="1000ms" data-wow-delay="900ms">
            <div class="">
                <h4>Newsletter Registration</h4>
                <p>Subscribe today to receive the latest Corpboot news via email. You may unsubscribe from this service
                    at any time</p>
            </div>
        </div>

    </div>
</footer>

<div class="sub-footer">
    <div class="container">
        <div class="social-icon">
            <div class="col-md-6">
                <ul class="social-network">
                    <li><a href="#" class="fb tool-tip" title="Facebook"><i class="fa fa-facebook"></i></a></li>
                    <li><a href="#" class="twitter tool-tip" title="Twitter"><i class="fa fa-twitter"></i></a></li>
                    <li><a href="#" class="gplus tool-tip" title="Google Plus"><i class="fa fa-google-plus"></i></a></li>
                    <li><a href="#" class="linkedin tool-tip" title="Linkedin"><i class="fa fa-linkedin"></i></a></li>
                    <li><a href="#" class="ytube tool-tip" title="You Tube"><i class="fa fa-youtube-play"></i></a></li>
                </ul>
            </div>
        </div>

        <div class="col-md-6 ">
            <div class="copyright text-right">
                &copy; Anyar Theme. All Rights Reserved.
                <div class="credits">
                    <!--
                      All the links in the footer should remain intact.
                      You can delete the links only if you purchased the pro version.
                      Licensing information: https://bootstrapmade.com/license/
                      Purchase the pro version with working PHP/AJAX contact form: https://bootstrapmade.com/buy/?theme=Anyar
                    -->
                    Designed by <a href="https://bootstrapmade.com/">BootstrapMade</a>
                </div>
            </div>
        </div>
    </div>
</div>


<!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
<script src="articles/js/jquery.js"></script>
<!-- Include all compiled plugins (below), or include individual files as needed -->
<script src="articles/js/bootstrap.min.js"></script>
<script src="articles/js/wow.min.js"></script>
<script src="articles/js/jquery.easing.min.js"></script>
<script src="articles/js/jquery.isotope.min.js"></script>
<script src="articles/js/functions.js"></script>
<script src="articles/js/expand.js"></script>
<script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5dabf708390cde0019866f87&product=inline-share-buttons" async="async"></script>

</body>
<script id="dsq-count-scr" src="//bioinformaticbrothers.disqus.com/count.js" async></script>
</html>
